Zugriffe | |
---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 185 |
Januar 2025 | Februar 2025 | März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | |
---|---|---|---|---|---|---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 1 | 14 | 6 | 18 | 10 | 4 | 0 |
Zugriffe | |
---|---|
2021_Zirngibl_etal.pdf | 220 |